Politicizing NIH Grants Weakens Research Risk Oversight
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- The Office of Management and Budget proposed a rule requiring political appointees to review grants and certify they "demonstrably advance the President's policy priorities" and do not "promote anti-American values," with the comment period closing July 13 and finalization aimed for the end of August.
- Under the proposed rule, the government could terminate any grant that no longer "effectuate[s]… the national interest" — a standard critics say gives the president unilateral authority to kill disfavored research.
- The National Institutes of Health invented the institutional review board (IRB) framework in the 1950s to oversee human-subject research, decades before Congress or the FDA adopted it as a legal requirement for federally funded studies.
- NIH has been the de facto regulator of genetic engineering since the 1970s, writing biosafety rules as a funding condition on its own initiative — a model Congress later adapted when it created mandatory oversight of the most dangerous pathogens in the 2000s.
- Both the IRB and biosafety regimes succeeded, the article argues, because NIH leaders and academic scientists operated as peers rather than adversaries, a dynamic that would collapse if researchers came to view the agency as a political instrument.
- NIH, working with its grantees, could pilot new policies governing AI-enabled biosecurity risks — such as regulating the movement of sensitive viral data or gatekeeping access to advanced biological AI models — but only if grantmaking stays grounded in scientific merit rather than partisan priorities.
Why it matters: If OMB finalizes the rule by its end-of-August target, the NIH's century-long, peer-based model of partnering with researchers to self-regulate emerging risks — from clinical trials to gene editing to frontier AI — loses its foundation the moment scientists see the agency as a political tool rather than a collaborator.
